Clinical Trial: Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE)

U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07603557) titled 'Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE)' on May 18.

Brief Summary: The purpose of this study is to evaluate the safety and efficacy of Zola-cel (BMS-986353), in participants with chronic immune thrombocytopenia (cITP) and autoimmune hemolytic anemia (AIHA).

Study Start Date: June 15

Study Type: INTERVENTIONAL

Condition: Chronic Immune Thrombocytopenia Autoimmune Hemolytic Anemia

Intervention: BIOLOGICAL: BMS-986353

Specified dose of specified days

DRUG: Fludarabine Phosphate

Specified dose of specified days

DRUG: Cyclophosphamide

Specified dose on specified days

Recruitme...